<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04382989</url>
  </required_header>
  <id_info>
    <org_study_id>MPS-2017</org_study_id>
    <nct_id>NCT04382989</nct_id>
  </id_info>
  <brief_title>Factors Influencing the Composition of Human Milk</brief_title>
  <official_title>The Influence of Various Maternal, Infant and Environmental Factors on Human Milk Composition Among Lithuanian Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vilnius University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Cagliari</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Vilnius University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims for characterization of different maternal, infant and environmental factors
      (e.g. maternal age, pregnancy duration, lactation period, baby gender, circadian rhythm,
      Holder pasteurisation, etc.) that influence human milk composition.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study consists of three parts. In the first part the investigators aim to evaluate human
      milk macronutrient composition depending on the time after delivery and pregnancy duration.

      In the second part the investigators aim to evaluate the circadian variation of human milk
      macronutrient and energy content depending on pregnancy duration.

      In the third part the investigators aim to evaluate the influence of Holder pasteurisation on
      human milk macronutrient, metabolome and bioactive protein (lysozyme and lactoferrin)
      content.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 15, 2017</start_date>
  <completion_date type="Actual">April 30, 2020</completion_date>
  <primary_completion_date type="Actual">April 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Quantification of total protein concentration in human milk</measure>
    <time_frame>from the 2nd week, up to 2 months after delivery</time_frame>
    <description>Mid-infrared spectrophotometry</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quantification of total lipids and carbohydrate in human milk</measure>
    <time_frame>from the 2nd week, up to 2 months after delivery</time_frame>
    <description>Mid-infrared spectrophotometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantification of lactoferrin in human milk</measure>
    <time_frame>14-16 days after delivery</time_frame>
    <description>An immune-enzymatic ELISA assay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantification of lysozyme in human milk</measure>
    <time_frame>14-16 days after delivery</time_frame>
    <description>An immune-enzymatic ELISA assay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Human milk metabolome analysis</measure>
    <time_frame>15-17 days after delivery</time_frame>
    <description>Nuclear Magnetic Resonance (NMR) analysis</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">174</enrollment>
  <condition>Breast Milk Collection</condition>
  <arm_group>
    <arm_group_label>Mothers of extremely preterm infants</arm_group_label>
    <description>(gestational age &lt; 28 weeks)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mothers of very preterm infants</arm_group_label>
    <description>(gestational age 28 - 31 weeks)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mothers of moderate and late preterm infants</arm_group_label>
    <description>(gestational age 32 - 36 weeks)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mothers of term infants</arm_group_label>
    <description>(gestational age â‰¥ 37 weeks)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Analysis of human milk composition by mid-infrared spectrophotometry</intervention_name>
    <description>Analysis of human milk macronutrient content was performed by mid-infrared spectrophotometry using a Miris Human Milk Analyser.
An immune-enzymatic ELISA assays were used to estimate lysozyme and lactoferrin concentrations in human milk.</description>
    <arm_group_label>Mothers of extremely preterm infants</arm_group_label>
    <arm_group_label>Mothers of moderate and late preterm infants</arm_group_label>
    <arm_group_label>Mothers of term infants</arm_group_label>
    <arm_group_label>Mothers of very preterm infants</arm_group_label>
    <other_name>Holder pasteurisation</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Mothers of newborns admitted at Neonatal Center of Vilnius University Hospital Santaros
        Klinikos, Lithuania
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        having obtained informed consent; after a single-birth pregnancy; women who were not on a
        special diet; lactating mothers who could not breastfeed their newborns due to the baby's
        medical condition (either prematurity or disease) but who expressed milk.

        -

        Exclusion Criteria:

        breastfeeding mothers; history of maternal diabetes, hepatitis B or C, HIV, tuberculosis,
        mastitis, or oncological disease; drug addicted.

        -
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Lactating women</gender_description>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vytautas Usonis, MD</last_name>
    <role>Study Director</role>
    <affiliation>Vilnius University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Neonatal centre of Vilnius University Hospital Santaros Klinikos</name>
      <address>
        <city>Vilnius</city>
        <zip>08406</zip>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Lithuania</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>May 6, 2020</study_first_submitted>
  <study_first_submitted_qc>May 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 11, 2020</study_first_posted>
  <last_update_submitted>June 2, 2020</last_update_submitted>
  <last_update_submitted_qc>June 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

